AQR Capital Management
ALIM

AQR Capital Management’s Alimera Sciences ALIM Stock Holding History

AQR Capital Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,240
Closed -$86K – 2279
2015
Q2 		$86K Sell
1,240
-1,780
-59% -$123K ﹤0.01% 2176
2015
Q1 		$227K Sell
3,020
-507
-14% -$39.9K ﹤0.01% 1979
2014
Q4 		$293K Buy
3,527
+27
+0.8% +$2.19K ﹤0.01% 2216
2014
Q3 		$285K Hold
3,500
– – ﹤0.01% 2208
2014
Q2 		$314K Buy
3,500
+1,153
+49% +$102K ﹤0.01% 2193
2014
Q1 		$278K Buy
+2,347
New +$228K ﹤0.01% 2295

Other funds holding ALIM

SM
Scale Management Foster City, California $359M AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

AQR Capital Management's ALIM Position: Q3 2015 in Review

AQR Capital Management sold out of Alimera Sciences (ALIM) in Q3 2015, closing a stake of 1,240 shares — an estimated $86K sold.

AQR Capital Management first reported a position in ALIM in Q1 2014 and held it in 6 quarters. The position peaked at $314K in Q2 2014. 63 funds tracked by Wall St. Rank hold ALIM as of Q3 2015.

  • AQR Capital Management reported no remaining Alimera Sciences position as of Q3 2015 after selling out during the quarter.
  • AQR Capital Management sold 1,240 Alimera Sciences shares in Q3 2015, an estimated $86K.
  • AQR Capital Management first reported a position in Alimera Sciences in Q1 2014 and held it in 6 quarters.
  • AQR Capital Management's Alimera Sciences position peaked at $314K in Q2 2014.
  • 63 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2015.

Based on AQR Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.